What is LivaNova's AFS securities?

LivaNova (LIVN) reported AFS securities of $3M in Q1 2026.

What is the long-term trend for LivaNova's AFS securities?

Over 2 years (2020 to 2025), LivaNova's AFS securities has grown at a -68.9% compound annual growth rate (CAGR), from $31.1M to $3M.

What does AFS securities mean?

Debt securities classified as available-for-sale, measured at fair value with unrealized gains/losses in OCI rather than the income statement.

LivaNova LIVN AFS Securities

AFS Securities at other companies

MedtronicMDT

——

Globus MedicalGMED

——

Other financials

Income statement

See full

Revenue$362.3M+14.3%

Gross profit$243.7M+12.7%

Operating income$41.5M-14.7%

Net income$22.3M+107%

EPS (diluted)$0.40+107%

Balance sheet

See full

Cash & equivalents$539.7M-26.9%

Total debt$340.9M-49.7%

Total equity$1.2B+17.1%

Total assets$2.5B-1.7%

Cash flow

See full

Operating cash flow$15.2M-36.5%

CapEx$14.3M+32.4%

Free cash flow$926.0K-93.0%

Valuation

See full

Market cap$4.32B+62.8%

Profitability

See full

Gross margin67.5%-0.5pp

Operating margin13.4%+0.8pp

Net margin-16.1%-18.0pp

FCF margin11.2%-0.2pp

Returns & leverage

See full

Return on equity-17.6%-19.5pp

Debt / equity0.3×-0.4×

Current ratio1.3×-0.2×

Where this comes from

Reported directly by LivaNova in its filing.

Tagged under the XBRL concept us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest.

The official record: LivaNova’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about LivaNova's afs securities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is LivaNova's AFS securities?: LivaNova (LIVN) reported AFS securities of $3M in Q1 2026.
What is the long-term trend for LivaNova's AFS securities?: Over 2 years (2020 to 2025), LivaNova's AFS securities has grown at a -68.9% compound annual growth rate (CAGR), from $31.1M to $3M.
What does AFS securities mean?: Debt securities classified as available-for-sale, measured at fair value with unrealized gains/losses in OCI rather than the income statement.